Method for detecting and localizing insulation failures of implantable device leads

ABSTRACT

The invention relates to a method and apparatus for diagnosis of conductor anomalies, such as insulation failures, in an implantable medical device, such as an implantable cardioverter defibrillator (ICD), a pacemaker, or a neurostimulator. Insulation failures are detected and localized by identifying changes in electrical fields via surface (skin) potentials. Small variations in potential are detected along the course of the electrode near the site of insulation failure.

RELATED APPLICATION

The present application claims the benefit of U.S. ProvisionalApplication No. 61/689,189 filed Jun. 1, 2012, which is incorporatedherein in its entirety by reference.

FIELD OF THE INVENTION

The present invention relates, generally, to scientific and medicalsystems, apparatus and methods. More particularly, the invention relatesto method and apparatus for diagnosis of conductor anomalies. Mostparticularly, the invention relates to a method and apparatus fordiagnosis of conductor anomalies, such as insulation failures, in animplantable medical device, such as an implantable cardioverterdefibrillator (ICD), a pacemaker, or a neurostimulator. Insulationfailures are detected and localized by identifying changes in electricalfields via surface (skin) potentials. Small variations in potential aredetected along the course of the electrode near the site of insulationfailure.

BACKGROUND

The long-term reliability and safety of implantable cardiac leads is asignificant issue. Anomalies of conductors in implantable medicaldevices constitute a major cause of morbidity. Representative examplesof such medical devices include, but are not limited to, pacemakers,vagal nerve stimulators, pain stimulators, neurostimulators, andimplantable cardioverter defibrillators (ICDs). For example, earlydiagnosis of ICD lead conductor anomalies is important to reducemorbidity and/or mortality from loss of pacing, inappropriate ICDshocks, and/or ineffective treatment of ventricular tachycardia orfibrillation (ventricular fibrillation). The early diagnosis ofconductor anomalies for implantable cardiac leads is a criticallyimportant step in reducing these issues and making ICDs safer.

Multilumen ICD defibrillation electrodes or leads include one or morehigh-voltage conductors and one or more pace-sense conductors. The leadscan be implanted as subcutaneous or intravascular leads. Insulationfailures have been known to result in functional failure of thecorresponding conductor. Functional failure of a pace-sense conductormay result in symptoms caused by loss of pacing functions forbradycardia, cardiac resynchronization, or antitachycardia pacing.Functional failure of a high-voltage conductor may result in fatalfailure of cardioversion or defibrillation.

Thus, one major goal is high sensitivity of diagnosis: identification oflead insulation failures at the subclinical stage, before they presentas a clinical problem. A second major goal is high specificity: a falsepositive provisional clinical diagnosis of lead insulation failure maytrigger patient anxiety and lead to potentially-avoidable diagnostictesting. A false positive clinical diagnosis of insulation failureresults in unnecessary lead replacement, with corresponding expense andsurgical risk.

Insulation failures occur most commonly at three regions along thecourse of a pacemaker or ICD lead. The first region is within thepocket, caused either by abrasion of the lead insulation by pressurefrom the housing (“CAN”) of the pulse generator or twisting of the leadwithin the pocket. The second region is that between the clavicle andfirst rib, where the lead is subject to “clavicular crush.” The thirdregion is the intracardiac region near the tricuspid valve. This thirdregion is a particularly common site of insulation failure for the St.Jude Riata® lead which is subject to “inside-out” insulation failure dueto motion of the internal cables relative to the outer insulation.

It is extremely difficult to detect and localize lead insulationfailures on an ICD implanted in the chest of a patient. The taking ofx-rays has been attempted to easily identify anomalies but has hadextremely limited success, and essentially zero success where theanomaly is a lead insulation failure. For example, FIG. 1 is an x-ray ofan implanted ICD, the arrow showing a small area of insulation stressfrom a tight suture (taken from Radiography of Cardiac ConductionDevices: A Comprehensive Review by Amanda L. Aguilera, M D, Yulia V.Volokhina, D O and Kendra L. Fisher, M D, October 2011 RadioGraphics,31, 1669-1682). Whether this area of insulation stress has already ledto an insulation failure or not is impossible to discern from thisimage.

Due to the failure of x-ray diagnosis, the primary method in the priorart for monitoring pacemaker and ICD lead integrity is periodicmeasurement of electrical resistance, usually referred to as “impedancemonitoring.” Impedance monitoring uses single pulses. Various methodswell-known in the art provide a measure of impedance close to thedirect-current resistance.

However, another common issue is that insulation failures commonlypresent clinically without detected changes in impedance as measured bypresently used methods. There are several possible explanations. Oneexplanation is that the range of impedance in normally functioning leadsmay be wide. For example, it has been reported that high-voltageimpedance in normally functioning high-voltage leads may fallapproximately 30% from maximum measured values (Gunderson B D,Ellenbogen K A, Sachanandani H, Wohl B N, Kendall K T, Swerdlow C D.Lower impedance threshold provides earlier warning for high voltage leadfractures. Heart Rhythm 8:S19, 2011). Similarly, the range of impedancefor pace-sense leads can vary widely. A second explanation is thatimpedance is determined primarily by body tissue, so that even if anin-pocket insulation failure is present, a test pulse delivered fromhousing to the affected electrode may not detect the insulation failureunless dielectric breakdown is complete.

The difficulty in detecting an insulation failure with presentelectrical testing may be appreciated from this example. Consider afracture in the conductor leading to the SVC coil (SVC conductor). Sucha fracture—in its initial stages—may have an impedance (to the bodycore) of 2 kΩ or more. The typical SVC coil has an impedance on theorder of 60Ω Thus the parallel combination of the normal impedance andthe “leakage” impedance (from the fracture) would result in an impedancereduction of 1.8Ω which is far lower than the typical (5-10Ω) serialimpedance changes seen chronically. Similar difficulties are seen withinsulation failures on pace/sense conductors as the tip and ringimpedances change significantly with fibrosis and other chronic effects.

In the circuit being measured, most of the resistance is at theelectrode-tissue interface of the high-resistance tip electrode, andvariations of up to 10% in this value are common. Each individualpace-sense conductor (for example, the conductor to the tip electrode orthe ring electrode) contributes less than 10% to the measuredresistance. In some ICD leads, this value is less than 3%. Thus even ifthe resistance in a single conductor doubled or tripled, the overallmeasured resistance will remain within the expected range. Measurementsindicate that resistance exceeds the expected range until the conductorhas lost most of its structural integrity. Thus, resistance remainswithin the expected range even when only a fraction of the conductor isintact. For this reason, resistance measurements are insensitive topartial loss of conductor integrity. Further, resistance measurementshave limited specificity. A single, out-of-range value may be anartifact, and marked increases can occur at the electrode-myocardialinterface.

In addition to limited sensitivity, present methods for diagnosing leadconductor anomalies have limited specificity resulting in false positivediagnostics. Evaluation of false positive diagnostics adds cost and workto medical care and may contribute to patient anxiety. If afalse-positive diagnostic is not diagnosed correctly, patients may besubject to unnecessary surgical lead replacement with its correspondingrisks. In the only report on this subject, 23% of leads extracted forthe clinical diagnosis of lead fracture tested normally after explant.

Any clinical method for detecting conductor anomalies in implanted leadsmust make measurements while the conductor and lead are in the body.Typically, the measuring circuit includes the conductor-tissue interfacein the body. Thus the measured values will depend both on the behaviorof the conductor being evaluated and the conductor-tissue interface.

Existing technology for diagnosis of conductor anomalies in animplantable medical device is believed to have significant limitationsand shortcomings. What is desired are method and apparatus that couldanalyze and identify implantable cardiac lead conductor anomalies at thesubclinical stage, before they present as a clinical problem, and do sowith a high sensitivity and specificity that minimizes false positivesfor implantable cardiac lead conductor anomalies.

SUMMARY OF THE INVENTION

The disclosed method and apparatus relates to the diagnosis of conductoranomalies, such as insulation failures, in an implantable medicaldevice, such as an implantable cardioverter defibrillator (ICD), apacemaker, or a neurostimulator. Insulation failures are detected andlocalized by identifying changes in electrical fields via surface (skin)potentials. Small variations in potential are detected along the courseof the electrode near the site of insulation failure. Pulses deliveredto the affected conductor result in the appearance of local electricalequipotential lines, further resulting in a disturbance of localpotentials recorded within the body or on the body surface viaelectrodes on the skin.

One embodiment is a detection method for an insulation failure of apacing conductor. An insulation failure is checked for in either the tippacing-sensing electrode or the ring pace-sense electrode. Low amplitudetest pulses with short duration<1.5 ms are delivered in a “bipolar”fashion between the “tip” sense conductors and the “ring” senseconductors. Pulses may be delivered in the absolute refractory periodafter a paced or conducted beat and use a higher output at pulsegenerator change with background electrical noise. Due to the dipoleeffect of the closely-spaced “tip” pacing-sensing electrode and “ring”pacing-sensing electrode, the electrical potential lines are tightlylocated near these electrodes if the insulation around the conductors isintact.

An embodiment is disclosed for detecting an insulation failure in eitherthe tip or ring conductor. In operation, a single recording electrode ismoved along the surface of the body parallel to the path of theimplanted lead. Another embodiment can utilize multiple simultaneousrecordings on the surface of the body, e.g., one over the surgicalpocket and intravascular/intracardiac course of the lead. Anotherembodiment can utilize an array of electrodes deployed in fixedpositions over the surface of the body. Further, although theembodiments described utilize the ICD's electronics as the source oftest pulses, test pulses may also be delivered at pulse generator changeusing an external test device such as a programmer.

In this embodiment, the patient is connected to a high-fidelity ECGunit. The high-fidelity ECG unit reliably displays bipolar transvenouspacing pulses, in order to detect the pacing pulses. The test pulsevoltage is reduced below the pacing threshold to minimize pacing. Thepacing rate is set to a rate faster than the spontaneous ventricularrate in the asynchronous (VOO mode) to provide more pulses to detect andto avoid most QRS complexes. A cutaneous electrode is moved along thesurface of the body parallel to the path of the implanted lead. A localmaximum voltage spike is searched for. If a local spike, of sufficientamplitude (e.g. >1 mV) is located sufficiently far away from the tip ofthe lead then an insulation break is indicated.

An embodiment is disclosed for detecting an insulation failure indefibrillation conductors in dual-coil systems. The ICD delivers acontinuous high-frequency AC impedance test between the SVC and RVelectrodes with the ICD housing turned off. The patient is connected toa high-fidelity ECG unit to detect the pacing pulses. The impedancetesting high-frequency signal is turned on by initiating an impedancetest. An electrode is moved along the surface of the body parallel tothe path of the implanted lead. A local maximum voltage spike issearched for. If a local spike, of sufficient amplitude is locatedsufficiently far away from the tip of the lead then an insulation breakis indicated.

An embodiment is disclosed for detecting an insulation failure indefibrillation conductors in single-coil systems. The ICD is modified todeliver a continuous high-frequency AC impedance test between the RVelectrodes and the ICD housing. The patient is connected to ahigh-fidelity ECG unit to detect the pacing pulses. The impedancetesting high-frequency signal is turned on by initiating an impedancetest. An electrode is moved along the path of the implanted lead and alocal voltage null is searched for. Without any insulation break, thereshould be a large signal near the ICD can and a large signal near the RVcoil. The voltage of this signal is expected to gradually decrease whenmoving from the can to the RV coil with a polarity inversion (and nowvoltage null) in between. If a local spike (away from the coil) islocated then an insulation break is detected.

In an embodiment, localization of the failure where the insulationfailure is adjacent to the ICD housing is disclosed. Pulses or acontinuous high-frequency alternating current are delivered over thethree current paths corresponding to the three electrodes on the leadwhich include the pace-sense (tip-ring) dipole, the ring-RV coil dipole,and the tip-RV coil dipole. In no case should there be evidence ofcurrent flow near the pocket or directly under the clavicle (clavicularcrush). By determining which dipole or dipoles do not result in ananomalous potential near the housing, identification of the remainingconductor can be made as having failed insulation.

Another embodiment for localizing an insulation break is disclosed.Localization of the break can be accomplished via a high-resolutioninverse-ECG system that is modified to provide potentials along the pathof the lead with the suspected insulation break. The method is performedby modifying inverse-ECG system to calculate potentials along the lead.The next step is connecting the patient to the inverse-ECG system andthen delivering pacing or AC impedance test stimuli. The steps furtherinclude locating maximum signals that are not at an electrode andlocalizing the insulation break to the region of maximum signal that arenot adjacent to a stimulated electrode.

In an embodiment, the test signals as generated in the embodiments ofthe methods about are generated from an implantable pulse generator. Inanother embodiment, an apparatus including an external test device, suchas programmer module, is utilized with the implant device. The apparatushas an AC amplifier, an AC generator, a filter, a modulator and adigital meter. In an embodiment, the AC generator is configured todeliver a sine wave to the implanted leads during a procedure thatinvolves disconnecting the leads from the pulse generator. Typically,this occurs for a device change due to battery depletion or infection.The frequency of the sine wave is chosen so that it is above thefrequencies that affect cardiac cells. In embodiments, a voltage of isdelivered to give a strong signal at the skin surface.

In an embodiment, a number of ECG adhesive electrodes would be placed inthe region of the implantable lead and be connected to a switch-box. Theoperator would then select the desired electrode, one at a time. The“reference” electrode would be a subcutaneous electrode in the devicepocket. As the clinician moves the roving electrode, via the switch-box,the digital meter displays the signal at each skin location and is thusable to find the skin location with the strongest signal.

BRIEF DESCRIPTION OF THE DRAWINGS

The invention may be more completely understood in consideration of thefollowing detailed description of various embodiments of the inventionin connection with the accompanying drawings, in which:

FIG. 1 shows a radiograph or x-ray of an implantable cardioverterdefibrillator (ICD) implanted in a human body where the lead has a smallarea of insulation stress from a tight suture.

FIG. 2A is a cross-sectional view of the Medtronic Quattro Secure® Lead,a multi-lumen ICD implantable cardiac lead.

FIG. 2B is a cross-sectional view of the Medtronic Sprint Fidelis® Lead,a multi-lumen ICD implantable cardiac lead.

FIG. 3 is a cross-sectional view of the St. Jude Medical Riata® Lead, amulti-lumen ICD implantable cardiac lead.

FIG. 4 illustrates regions within the human body associated with theimplantation of an ICD and associated leads.

FIG. 5 shows an implantable medical device in which an embodiment of thepresent invention may be practiced. It shows an ICD pulse generatorconnected to a patient's heart via a transvenous cardiac lead used forpacing and defibrillation.

FIG. 6 shows an ICD pulse generator connected to a patient's heart via atransvenous cardiac lead used for pacing and defibrillation where thelead contains an insulation failure nearer the ICD.

FIG. 7 shows an ICD pulse generator connected to a patient's heart via atransvenous cardiac lead used for pacing and defibrillation where thelead contains an insulation failure nearer the ICD and the method ofchecking for failure in either the tip or ring pace-sense conductors.

FIG. 8 is a flowchart depicting the method of detecting an insulationfailure in either the tip or ring pacing conductor.

FIG. 9 is a flowchart depicting the method of detecting an insulationfailure in defibrillation conductors in dual-coil systems.

FIG. 10 is a flowchart depicting the method of detecting an insulationfailure in defibrillation conductors in single-coil systems.

FIG. 11 is a flowchart depicting the method of localizing an insulationfailure.

FIG. 12 illustrates an apparatus used to generate test signals anddisplay the amplified signal amplitude.

While the invention is amenable to various modifications and alternativeforms, specifics thereof have been shown by way of example in thedrawings and will be described in detail. It should be understood,however, that the intention is not to limit the invention to theparticular embodiments described. On the contrary, the intention is tocover all modifications, equivalents, and alternatives falling withinthe spirit and scope of the invention as defined by the appended claims.

DETAILED DESCRIPTION

The embodiments herein are directed to the diagnosis of lead orconductor anomalies, such as insulation failures, in an implantablemedical device, such as pacemakers, vagal nerve stimulators, painstimulators, neurostimulators, and implantable cardioverterdefibrillators (ICDs). However, for clarity, discussion of lead orconductor anomalies will be made in reference to ICDs. However, thosewith skill in the art are cognizant of the fact that the methods andapparatus as disclosed herein are suitable for use with any one of thevarious implantable medical devices.

FIGS. 2A, 2B and 3 depict known multi-lumen ICD defibrillationelectrodes or leads that have been diagnosed with lead conductoranomalies. While these are indicative of the type of leads that can bediagnosed, anomalies in any type of defibrillation electrodes or leadsare capable of being diagnosed with the methods and apparatus asdisclosed herein. FIG. 2A depicts the Medtronic Quattro Secure® Lead.FIG. 2B depicts the Medtronic Sprint Fidelis®Lead. FIG. 3 depicts theSt. Jude Medical Riata® Lead. The leads 10, while having variousconstructions, have similar features. These similar features areidentified with the same reference numbers in the figures.

The implantable cardiac lead 10 is comprised of a lumen 12 and centerinner pacing coil 14 surrounded by PTFE insulation 16, a plurality oflumens 18 each containing at least one conductor 20 with each conductor20 surrounded by ETFE insulation 22, an outer insulating layer 24, and asilicone insulation 26 disposed between the lumen 12 and the outerinsulating layer 24. The conductors 20 include a sense conductor 21, ahigh voltage RV conductor 23 and a high voltage SVC conductor 25. Theplurality of lumens 18 are disposed in the silicone insulation 26. Theconductors 20 carry electric current to the pace-sense electrodes 66,68, high voltage RV coil 64 and high voltage SVC coil 62.

As discussed above, and shown in FIG. 4, insulation failures mostcommonly occur at three regions along the course of a pacemaker or ICDlead 10. The first region 42 is proximate the pocket, caused either byabrasion of the lead 10 insulation 24 by pressure from the housing(“CAN”) of the pulse generator or twisting of the lead 10 within thepocket. The second region 44 is that between the clavicle and first rib,where the lead 10 is subject to “clavicular crush.” The third region 46is the intracardiac region near the tricuspid valve. This third region46 is a particularly common site of insulation 24 failure for the St.Jude Riata® lead 10 which is subject to “inside-out” insulation failuredue to motion of the internal conductors 20 relative to the outerinsulation 24.

FIG. 5 depicts on ICD 52 implanted in the chest of a patient. The ICD 52has an outer housing 54, commonly referred to as a “CAN,” innercircuitry 56 and a battery 58. Connection is made to the heart 60 viathe lead 10. The lead 10 can have an optional proximal defibrillationcoil 62 which is near the superior vena cava (SVC) and is commonlyreferred to as the SVC coil 62. The lead 10 also has a distaldefibrillation coil 64 which is commonly referred to as theright-ventricular coil or RV coil 64. Also shown is the optional “ring”pacing-sensing electrode 66. Located at the distal end of the lead 10 isthe “tip” pacing-sensing electrode 68.

The outer insulating layer 24 of the leads 10 is generally a polymersuch as silicone, polyurethane, or a copolymer of silicone andpolyurethane. Stress on the insulation 24 from anchoring sutures,outside-in abrasion from contact with the housing, or inside-outabrasion from movement of the cables within the lead 10 may result ininsulation 24 breaches or failures. In addition, the insulation 24 canfail due to chemical reactions such as metal-ion oxidation.

FIG. 6 depicts a lead 10 insulation 24 failure at location 70. Whenpulses are delivered to the affected conductor 20 the local electricalequipotential lines appear approximately as those shown at 72. Thisresults in a disturbance of local potentials recorded within the body oron the body surface via electrodes on the skin.

FIG. 7 depicts an example of a detection method for pacing conductors14. In this embodiment, an insulation failure is checked for in eitherthe tip pacing-sensing electrode 68 or the ring pace-sense electrode 66.Low amplitude (<1 V) test pulses with duration<1.5 ms are delivered in a“bipolar” fashion between the “tip” sense conductors 21 and the “ring”sense conductors 21. Pulses may be delivered in the absolute refractoryperiod after a paced or conducted beat. The test pulse may be delivered,under sedation in a surgical suite, using a higher output at pulsegenerator change with background electrical noise. Due to the dipoleeffect of the closely-spaced “tip” pacing-sensing electrode 68 and“ring” pacing-sensing electrode 66, the electrical potential lines aretightly located near these electrodes 66, 68 if the insulation aroundthe conductors is intact, as shown by the smaller ovals 74. Note thatthese ovals in FIG. 7 represent a simplification of the actualequi-potential lines which are typically positive (+) around the “ring”pacing-sensing electrode 66 and negative (−) around the “tip”pacing-sensing electrode 68.

The amplitude of the skin-surface potential during bipolar pacing is onthe order of approximately 1 mV in a conventional lead and much weakerin other locations with high-fidelity ECG units. An example of ahigh-fidelity ECG unit is the GE MAC 5500 HD. Due to the high-frequencynature of the pacing pulse it is typically invisible on older ECG unitsdue to their low-pass filtering.

FIG. 8 depicts an embodiment of a method for detecting an insulationfailure in either the tip or ring conductor 20. Note that this method isable to be used for any pacing conductor such as endocardial electrodesin the right atrium, coronary sinus, or the left ventricle, as well asepicardial or subcutaneous electrodes. In operation, a single recordingelectrode is moved along the surface of the body parallel to the path ofthe implanted lead 10. Visual confirmation of the path can be providedby, for example, radiographic methods, such as an x-ray taken in one ormore views, or by CT scan. Another embodiment can utilize multiplesimultaneous recordings on the surface of the body, e.g., one over thesurgical pocket and intravascular/intracardiac course of the lead 10.Another embodiment can utilize an array of electrodes deployed in fixedpositions over the surface of the body. Further, although theembodiments described utilize the ICD's 52 electronics 56 as the sourceof test pulses, test pulses may also be delivered at pulse generatorchange using an external test device such as a programmer.

The method shown in FIG. 8 connects the patient to a high-fidelity ECGunit 80. The high-fidelity ECG unit reliably displays bipolartransvenous pacing pulses, in order to detect the pacing pulses. Thetest pulse voltage is reduced below the pacing threshold 81 to minimizepacing. The pacing rate is set to a rate faster than the spontaneousventricular rate 82 in the asynchronous (VOO mode) to provide morepulses to detect and to avoid most QRS complexes.

A cutaneous electrode is moved along the surface of the body parallel tothe path of the implanted lead 83. Visual confirmation of the path canbe provided by, for example, radiographic methods, such as an x-raytaken in one or more views, or by CT scan. The cutaneous electrodemovement includes the loops of lead in the pocket which is a common siteof insulation breach. A local maximum voltage spike is searched for 85.If a local spike, of sufficient amplitude (e.g. >1 mV) is locatedsufficiently far away from the tip of the lead then an insulation breakis detected 86. Else, an insulation break is not detected 87. If thepatient cannot tolerate a brief absence of pacing, then pacing isperformed at a rate between the lower and upper rate limits (inclusive)with the voltage set to the maximum.

FIG. 9 depicts an embodiment of a method for detecting an insulationfailure in defibrillation conductors in dual-coil systems. The methodcan detect a possible insulation break in either one of thedefibrillation conductors. The ICD is modified to deliver a continuoushigh-frequency AC impedance test between the SVC and RV electrodes withthe ICD housing turned off 91. The patient is connected to ahigh-fidelity ECG unit 92 such as a GE MAC 5500 HD in order to detectthe pacing pulses. The impedance testing high-frequency signal is turnedon by initiating an impedance test 93. An electrode is moved along thesurface of the body parallel to the path of the implanted lead 94.Visual confirmation of the path can be provided by, for example,radiographic methods, such as an x-ray taken in one or more views, or byCT scan. The electrode movement includes the loops of lead in the pocketwhich is a common site of insulation breach. A local maximum voltagespike is searched for as shown at 95. If a local spike, of sufficientamplitude is located sufficiently far away from the tip of the lead thenan insulation break is detected as shown at 97. Else, an insulationbreak is not detected as shown at 98.

FIG. 10 depicts an embodiment of a method for detecting an insulationfailure in defibrillation conductors in single-coil systems. The methodcan detect a possible insulation break in either one of thedefibrillation conductors. The ICD is modified to deliver a continuoushigh-frequency AC impedance test between the RV electrodes and the ICDhousing 101. The patient is connected to a high-fidelity ECG unit 102such as a GE MAC 5500 HD in order to detect the pacing pulses. Theimpedance testing high-frequency signal is turned on by initiating animpedance test 103. An electrode is moved along the path of theimplanted lead 104. Visual confirmation of the path can be provided by,for example, radiographic methods, such as an x-ray taken in one or moreviews, or by CT scan. A local voltage null is searched for at 105.Without any insulation break, there should be a large signal near theICD can and a large signal near the RV coil 108. The voltage of thissignal is expected to gradually decrease when moving from the can to theRV coil with a polarity inversion (and now voltage null) in between. Ifa local spike (away from the coil) is located then an insulation breakis detected at 107. Else, an insulation break is not detected at 108.

In the case of an insulation 24 failure adjacent to the ICD's 52 housing54, it is sometimes difficult to localize the failure using the abovetechniques of detecting a surface potential. In this type of scenario,pulses or a continuous high-frequency alternating current are deliveredover the three current paths corresponding to the three electrodes onthe lead which include the pace-sense (tip-ring) dipole, the ring-RVcoil dipole, and the tip-RV coil dipole. In no case should there beevidence of current flow near the pocket 42 or directly under theclavicle (clavicular crush) 44. By determining which dipole or dipolesdo not result in an anomalous potential near the housing, identificationof the remaining conductor can be made as having failed insulation 24.

FIG. 11 depicts a method of localizing an insulation break. Once aninsulation break is detected or indicated, localization of the break canbe accomplished via a high-resolution inverse-ECG system such as theCardio-Insight mapping system. The method requires that the system bemodified to provide potentials along the path of the lead with thesuspected insulation break. The method is performed by modifyinginverse-ECG system to calculate potentials along the lead 110. The nextstep is connecting the patient to the inverse-ECG system 112 and thendelivering pacing or AC impedance test stimuli. The steps furtherinclude locating maximum signals that are not at an electrode 116 andlocalizing the insulation break to the region of maximum signal that arenot adjacent to a stimulated electrode.

Additionally, for the embodiments as disclosed herein, a baselinerecording (or set of recordings) can be completed when the lead systembecomes stable, which is typically between one and three months afterimplant. The sites of maximum potential in subsequent testing may thenbe compared with sites of maximum potential during subsequent testingeither by the operator or by using custom software.

The above descriptions depict the duration of the testing process as anembodiment of a single test setting (e.g. at pulse generator change orin out-patient follow up). However, in other embodiments, the methodscan be practiced with a 24 hour to one week ambulatory recording periodthus providing an extended time period that can be used to effectivelyidentify intermittent lead insulation failure. In embodiments, therecording system may be activated by telemetry signals delivered by thepulse generator.

In an embodiment, the test signals as generated in the embodiments ofthe methods about are generated from an implantable pulse generator. Inanother embodiment, as shown in FIG. 12, an apparatus including anexternal test device, such as programmer module, is utilized at implant.and measurements from the cutaneous electrodes are analyzed in near realtime using the external test device. The apparatus 120 has an ACamplifier 122, an AC generator 124, a filter 126, a modulator 128 and adigital meter 130. One input of the AC amplifier is connected to theroving ECG electrode and the other input is connected to the referenceECG electrode. The AC amplifier output is fed into the filter 126, whichis depicted as a 10 kHz filter but it is not so limited. The filter 126is output to the modulator 128 and to the digital meter 130. The ACgenerator 124 is connected to the implanted leads. The AC generator 124is depicted as a 10 kHz AC generator but it is not so limited.Additionally the AC generator 124 is connected to the filter 126.

In an embodiment, the test pulses are delivered through the implantedpulse generator. Measurements from the cutaneous electrodes are thenstored in an ambulatory recording device or long-termelectrocardiographic event recorder. In some embodiments, the recordingdevice can be equipped with a larger electrode array as described hereinwith respect to other embodiments. After a specified monitoring period,e.g., 24 hour to one week to one month or longer ambulatory recordingperiod, the stored measurements are downloaded to an external analysisunit. In embodiments, the recording system may be activated by telemetrysignals delivered by the pulse generator. It is apparent to thoseskilled in the art that the ambulatory recording period can be anytimeframe as specified by the physician that is sufficient to accomplishthe purposes herein.

In an embodiment, the 10 kHz AC generator 124 is configured to deliver a10 V sine wave to the implanted leads 10 during a procedure thatinvolves disconnecting the leads 10 from the pulse generator. Typically,this occurs for a device change due to battery depletion or infection.The 10 kHz frequency is chosen as it is above the frequencies thataffect cardiac cells. In certain embodiments, frequencies of 5 to 25 kHzare used but, in other embodiments, frequencies of 1 to 250 kHz can beused. Care should be taken at lower frequencies because cardiac captureor collapse can occur with sufficient amplitudes. In embodiments, avoltage of 5 V AC is delivered to give a strong signal at the skinsurface. In other embodiments, voltages of 1 to 20 V AC are provided.

In an embodiment, the signal from the recording electrode or electrodesis fed thru the amplifier 122 and then filtered by a narrow-band filter126. The filter 126 can be either an analog or digital notch filter. Onanother embodiment, the filter can be a synchronous filter using thesignal 132 for synchronization from the generator 124. Extremely highsignal-to-noise ratios are thus achieved. The generator frequency andthe filter frequency should be the same.

In this embodiment, the roving electrode would not be physically moved.Rather, a number of ECG adhesive electrodes would be placed in theregion of the implantable lead 10 and be connected to a switch-box. Theoperator or a computerized system would then select the desiredelectrode, one at a time. The “reference” electrode would be asubcutaneous electrode in the device pocket 42.

The amplified signal is then modulated down to a lower frequency, e.g.,100 Hz, so that the signal can be readily processed by a conventionalECG unit. The digital meter 130 displays the amplified signal amplitude.As the clinician moves the roving electrode, via the switch-box, thedigital meter 130 displays the signal at each skin location and is thusable to find the skin location with the strongest signal. Additionally,an ECG unit is not required as the digital meter 130 displays thesignals.

In an alternative embodiment, the signal generator generates a 90 Hzsine wave which is easy to differentiate from utility 50/60 Hzinterference and has the advantage of passing readily thru any ECG unit.It does have the disadvantage of limited driving voltage as suchfrequencies can easily cause cardiac collapse.

The following patents and applications, the disclosures of which areincorporated by reference in this case (other than claims and expressdefinitions), are prior art attempts by common inventors to solve theproblem at issue: U.S. Pat. No. 8,352,033 (033) to Kroll, issued Jan. 8,2013; U.S. patent application Ser. No. 13/735,599 to Kroll, filed onJan. 7, 2013 which is a continuation of '033; and U.S. patentapplication Ser. No. 12/868,056 to Swerdlow, filed on Aug. 25, 2010.

The following provisional applications, the disclosures of which areincorporated by reference in this case (other than claims and expressdefinitions), are related to each other: U.S. Patent Application61/689,191 to Kroll and Swerdlow, filed on Jun. 1, 2012; U.S. PatentApplication 61/689,189 to Kroll and Swerdlow, filed on Jun. 1, 2012; andU.S. Patent Application 61/733,713 to Kroll and Swerdlow, filed on Dec.5, 2012.

The values noted above are example embodiments and should not be read aslimiting the scope of this invention. Those skilled in the art willrecognize that the above values may be adjusted to practice theinvention as necessary depending on the electrode implantable cardiaclead technology used and the physical characteristics of the patient.

While the present invention has been described with reference to certainembodiments, those skilled in the art should appreciate that they canreadily use the disclosed conception and specific embodiments as a basisfor designing or modifying other structures for carrying out the samepurposes of the present invention without departing from the spirit andscope of the invention as defined by the appended claims.

1. A method for detecting an insulation failure of an implantabledefibrillation lead, the defibrillation lead connected to an implantedelectromedical device and in electrical communication with a heart of apatient comprising: delivering at least one low amplitude testelectrical pulse that is below a pacing threshold having a pacing ratefaster than a spontaneous ventricular rate through at least oneconductor in the defibrillation lead; recording electrical potential atrecording sites, the recording sites being located at one or more bodylocations spaced apart from and relative to the path of thedefibrillation lead; and analyzing said electrical potential recordedfrom said recording sites to determine if a presence of an insulationfailure by realizing a local maximum voltage spike in said electricalpotential recorded from said recording sites.
 2. The method of claim 1wherein the delivering of at least one test electrical pulse is from theimplanted electromedical device.
 3. The method of claim 1 wherein thedelivering of at least one test electrical pulse is from an externaltest device.
 4. The method of claim 1 wherein the one or more bodylocations are along an exterior of a body surface.
 5. The method ofclaim 4 wherein recording electrical potential is accomplished via asingle roving electrode placed sequentially at different body surfacelocations.
 6. The method of claim 4 wherein recording electricalpotentials is accomplished via multiple electrodes.
 7. The method ofclaim 1 wherein recording electrical potential is accomplished viaelectrodes located within the body, the electrodes not being connectedto the implantable lead being analyzed for said insulation failure. 8.The method of claim 1 wherein the implanted electromedical device isselected from the group consisting of implantable cardioverterdefibrillators with transvenous leads, implantable cardioverterdefibrillators with subcutaneous leads, vagal nerve stimulators, painstimulators, pacemakers, and neurostimulators.
 9. The method of claim 1wherein the delivering of at least one test electrical pulse furthercomprises delivering a plurality of low amplitude test electricalpulses, wherein each of the plurality of low amplitude test electricalpulses are delivered at different voltages.
 10. The method of claim 1wherein a relative change in electrical potentials at differentrecording sites identifies the presence of the insulation failure. 11.The method of claim 1 wherein the implanted electromedical device is animplantable cardioverter defibrillator and the lead is a multilumendefibrillation lead.
 12. The method of claim 11 wherein the at least onetest electrical pulse is delivered through at least one pair ofconductors, the pair of conductors selected from the group consisting ofpace to sense, ring to right-ventricular coil, tip to right-ventricularcoil, and right-ventricular coil to superior vena cava coil.
 13. Themethod of claim 1 wherein the at least one test electrical pulse isdelivered through a multiplicity of pairs of conductors and theinsulation failure is identified by differences in the pattern ofrecorded electrical potentials.
 14. The method of claim 7 whereinrecording the potential is accomplished from at least one electrode, theelectrodes comprising: an implantable cardioverter defibrillatorhousing; and an electrode temporarily implanted within the surgicalpocket.
 15. The method of claim 1 wherein the at least one testelectrical pulse is delivered through an implanted pulse generator andmeasurements from cutaneous electrodes are analyzed in near real timeusing an external test device.
 16. The method of claim 1 furthercomprising: delivering the at least one test electrical pulse through animplanted pulse generator; storing measurements from cutaneouselectrodes in an ambulatory recording device or long-termelectrocardiographic event recorder; and downloading the storedmeasurements to an external analysis unit after a monitoring period. 17.The method of claim 16 further comprising activating data storage in theambulatory recording device via telemetry from the implanted pulsegenerator.
 18. The method of claim 1 further comprising: recording adistribution of body surface potentials in response to a plurality oftest pulses delivered via various combinations of conductors afterimplant; storing the distribution of body surface potentials as abaseline map; recording a subsequent distribution of body surfacepotentials; comparing the subsequent distribution of body surfacepotentials with the baseline map; and identifying an insulation failurerelative to the subsequent distribution of body surface potentialsdiffering sufficiently from the baseline map.
 19. The method of claim 1,wherein localizing the insulation failure comprises: detecting aninsulation failure; modifying a high resolution inverse-ECG system toprovide potentials along a path of the implantable lead; attaching theinverse-ECG system to the patient; delivering pacing or impedance teststimuli; locating maximum signals not at an electrode; and localizingthe insulation break to a region of maximum signal not adjacent to anelectrode.
 20. An apparatus for detecting implanted lead insulationfailures comprising: an AC signal generator operably connected to animplantable lead in a body; an AC amplifier having one input connectedto a roving electrode and one input connected to a reference electrode,the AC amplifier amplifying skin surface signals from the rovingelectrode; a filter connected to the amplifier output and to the outputof the AC signal generator, the filter configured to pass the signalcharacteristics of the AC signal generator; a modulator connect thefilter output, the output of the modulator provided to an ECG device;and circuitry connected to the filter output to enable reading of thefilter signal.
 21. The apparatus of claim 20 wherein the apparatus isused to perform the method of claim 1.